ARCHIVES

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

This article is from The Cancer Letter archive.

Vol. 17 No. 27 | July 5, 1991

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

NCI Publishes New Atlas Of Cancer Mortality

December 10, 1999

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Adamson, Henney Chair Silicone Task Force

April 25, 1992

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007